Boston Scientific (BSX) Tops Q2 EPS by 4c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $46.41 +6.69%
Financial Fact:
Income tax expense: 29M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income tax expense: 29M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.62, $0.04 better than the analyst estimate of $0.58. Revenue for the quarter came in at $4.12 billion versus the consensus estimate of $4.02 billion.
GUIDANCE:
Boston Scientific sees Q3 2024 EPS of $0.57-$0.59, versus the consensus of $0.57.
Boston Scientific sees FY2024 EPS of $2.38-$2.42, versus the consensus of $2.33.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Phoenix Education Partners (PXED) PT Lowered to $32 at Jefferies
- XPEL, Inc. (XPEL) Tops Q3 EPS by 4c, Misses on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
